| Gino Hidalgo Tagoylo, MD | |
|
2301 Bahamas Dr, Bakersfield, CA 93309-0663 | |
| (661) 326-9600 | |
| (661) 334-3065 |
| Full Name | Gino Hidalgo Tagoylo |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 17 Years |
| Location | 2301 Bahamas Dr, Bakersfield, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790982254 | NPI | - | NPPES |
| 1790982254 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD60281757 (Washington) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | A125922 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sutter Amador Hospital | Jackson, CA | Hospital |
| Sutter Coast Hospital | Crescent city, CA | Hospital |
| Sutter Medical Center, Sacramento | Sacramento, CA | Hospital |
| Curry General Hospital | Gold beach, OR | Hospital |
| Mark Twain Medical Center | San andreas, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mother Lode Diagnostic Imaging Inc | 9739176892 | 3 |
| Mother Lode Diagnostic Imaging Inc | 9739176892 | 3 |
News Archive
Gilead Sciences, Inc. today announced it is stopping ARTEMIS-IPF, the company's ongoing Phase III clinical trial of ambrisentan in patients with idiopathic pulmonary fibrosis (IPF), due to lack of efficacy. This decision follows an interim analysis of unblinded efficacy and safety data by the study's Data Monitoring Committee (DMC) and review of those data by Gilead, which did not show evidence of a treatment benefit in the group of patients randomized to receive ambrisentan.
A new study by researchers in Cleveland Clinic's Taussig Cancer Institute and Lerner Research Institute describes a novel class of targeted cancer drugs that may prove effective in treating certain common types of leukemia.
The American Nurses Credentialing Center has redesignated Sinai Hospital of Baltimore as a Magnet-recognized hospital, a distinction that honors nursing excellence in patient care, leadership and growth opportunities for nurses within a health care organization. US News & World Report uses the Magnet designation as a factor when ranking the best medical centers in 16 specialties.
A British pharmaceutical wholesaler and distributor, who specialises in exporting overseas licensed, restricted and out of stock pharmaceuticals and speciality products for rare diseases, will attend Arab Health 2017.
A study conducted at the Keck School of Medicine of the University of Southern California showed that 9-cis retinoic acid (alitretinoin) could significantly prevent postsurgical lymphedema.
› Verified 5 days ago
| Entity Name | Kern Radiology Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700821972 PECOS PAC ID: 7214826460 Enrollment ID: O20040315000421 |
News Archive
Gilead Sciences, Inc. today announced it is stopping ARTEMIS-IPF, the company's ongoing Phase III clinical trial of ambrisentan in patients with idiopathic pulmonary fibrosis (IPF), due to lack of efficacy. This decision follows an interim analysis of unblinded efficacy and safety data by the study's Data Monitoring Committee (DMC) and review of those data by Gilead, which did not show evidence of a treatment benefit in the group of patients randomized to receive ambrisentan.
A new study by researchers in Cleveland Clinic's Taussig Cancer Institute and Lerner Research Institute describes a novel class of targeted cancer drugs that may prove effective in treating certain common types of leukemia.
The American Nurses Credentialing Center has redesignated Sinai Hospital of Baltimore as a Magnet-recognized hospital, a distinction that honors nursing excellence in patient care, leadership and growth opportunities for nurses within a health care organization. US News & World Report uses the Magnet designation as a factor when ranking the best medical centers in 16 specialties.
A British pharmaceutical wholesaler and distributor, who specialises in exporting overseas licensed, restricted and out of stock pharmaceuticals and speciality products for rare diseases, will attend Arab Health 2017.
A study conducted at the Keck School of Medicine of the University of Southern California showed that 9-cis retinoic acid (alitretinoin) could significantly prevent postsurgical lymphedema.
› Verified 5 days ago
| Entity Name | Mother Lode Diagnostic Imaging Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053456061 PECOS PAC ID: 9739176892 Enrollment ID: O20040623001281 |
News Archive
Gilead Sciences, Inc. today announced it is stopping ARTEMIS-IPF, the company's ongoing Phase III clinical trial of ambrisentan in patients with idiopathic pulmonary fibrosis (IPF), due to lack of efficacy. This decision follows an interim analysis of unblinded efficacy and safety data by the study's Data Monitoring Committee (DMC) and review of those data by Gilead, which did not show evidence of a treatment benefit in the group of patients randomized to receive ambrisentan.
A new study by researchers in Cleveland Clinic's Taussig Cancer Institute and Lerner Research Institute describes a novel class of targeted cancer drugs that may prove effective in treating certain common types of leukemia.
The American Nurses Credentialing Center has redesignated Sinai Hospital of Baltimore as a Magnet-recognized hospital, a distinction that honors nursing excellence in patient care, leadership and growth opportunities for nurses within a health care organization. US News & World Report uses the Magnet designation as a factor when ranking the best medical centers in 16 specialties.
A British pharmaceutical wholesaler and distributor, who specialises in exporting overseas licensed, restricted and out of stock pharmaceuticals and speciality products for rare diseases, will attend Arab Health 2017.
A study conducted at the Keck School of Medicine of the University of Southern California showed that 9-cis retinoic acid (alitretinoin) could significantly prevent postsurgical lymphedema.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gino Hidalgo Tagoylo, MD 2301 Bahamas Dr, Bakersfield, CA 93309-0663 Ph: (661) 326-9600 | Gino Hidalgo Tagoylo, MD 2301 Bahamas Dr, Bakersfield, CA 93309-0663 Ph: (661) 326-9600 |
News Archive
Gilead Sciences, Inc. today announced it is stopping ARTEMIS-IPF, the company's ongoing Phase III clinical trial of ambrisentan in patients with idiopathic pulmonary fibrosis (IPF), due to lack of efficacy. This decision follows an interim analysis of unblinded efficacy and safety data by the study's Data Monitoring Committee (DMC) and review of those data by Gilead, which did not show evidence of a treatment benefit in the group of patients randomized to receive ambrisentan.
A new study by researchers in Cleveland Clinic's Taussig Cancer Institute and Lerner Research Institute describes a novel class of targeted cancer drugs that may prove effective in treating certain common types of leukemia.
The American Nurses Credentialing Center has redesignated Sinai Hospital of Baltimore as a Magnet-recognized hospital, a distinction that honors nursing excellence in patient care, leadership and growth opportunities for nurses within a health care organization. US News & World Report uses the Magnet designation as a factor when ranking the best medical centers in 16 specialties.
A British pharmaceutical wholesaler and distributor, who specialises in exporting overseas licensed, restricted and out of stock pharmaceuticals and speciality products for rare diseases, will attend Arab Health 2017.
A study conducted at the Keck School of Medicine of the University of Southern California showed that 9-cis retinoic acid (alitretinoin) could significantly prevent postsurgical lymphedema.
› Verified 5 days ago
Aida Karahmet, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: Truxtun Radiology Medical Group Lp, 1817 Truxtun Ave, Bakersfield, CA 93301 Phone: 661-325-6800 Fax: 661-325-4734 | |
Dr. Alan Mortezaie, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2301 Bahamas Dr, Bakersfield, CA 93309 Phone: 661-326-9600 Fax: 661-334-3065 | |
Dr. Marcher Thompson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2620 Chester Ave, Bakersfield, CA 93301 Phone: 661-637-8100 | |
Dr. Nicolas James Andrews, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 9602 Stockdale Hwy, Bakersfield, CA 93311 Phone: 661-633-5000 Fax: 661-633-2500 | |
Dr. James Yiu-tin Ching, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1700 Mount Vernon Ave, Kern Medical Center, Bakersfield, CA 93306 Phone: 661-326-2532 Fax: 661-326-2648 | |
Dr. Arsalan Asad Siddiqui, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4500 Morning Dr Ste 202, Bakersfield, CA 93306 Phone: 951-550-2516 | |
David Gregory Suadi, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 4000 Empire Dr Ste 100, Bakersfield, CA 93309 Phone: 661-631-8000 Fax: 661-631-8005 |